Lobbyists Again Coordinate Device Tax Attack
AdvaMed and MDMA, two rivaling lobby groups, have again come together against a common enemy: the Obamacare medical device excise tax. The groups simultaneously released survey results that argue that permanently repealing the tax would be a boon for their member companies and innovation.
You may also be interested in...
The first step to repealing the Affordable Care Act was taken by the Senate early in the morning of Jan. 12 when it passed a budget resolution bill clearing the way for a Republican "repeal-and-replace" package. The bill will include device tax repeal and be brought to incoming President Trump's desk as soon as February, according to congressional leaders.
Industry representatives – including the head of the Access to Medical Imaging Coalition and a former chief operating officer at Boston Scientific – remain unconcerned about expected major drops in health insurance coverage if a Republican-controlled Congress and HHS secretary appointee Tom Price repeal Obamacare this year, saying that proposed Republican replacement plans will fill the gap. Current HHS Secretary Sylvia Burwell disagrees, and laid out the reasons why in a Jan. 9 speech.
The Minnesota congressman is taking another stab at chopping off the 2.3 medical device excise tax as part of the wider Obamacare repeal actions anticipated for the new Congress.